Archives

by in
Entry Author Date Location
Acucela Pins Down $162M IPO in Japan to Develop Eye Drugs 02/04/14 Seattle
Stem Cells, Inc. Expanding Trial in Age-Related Eye Affliction 12/18/13 San Francisco
Acucela Seeks $125M IPO in Japan to Develop Eye Drugs 12/17/13 Seattle
Acucela, Turning 10, Gears Up for Pivotal Test With Eye Drug 06/12/12 Seattle
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
Acucela Adds Finance Chief 04/26/11 Seattle
Who Will Keep the Flame Alive for Seattle Biotech? Hear From the Players Nov. 29 11/09/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
Acucela, Strengthening Ties With Japan’s Otsuka, Gets Right to Develop New Glaucoma Drug 09/27/10 Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News 03/25/10 Seattle
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs 03/19/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
Acucela Gets FDA Fast Track 03/17/10 Seattle
Biotech Bigwig, Steve Burrill, Brings National Profile to Local Conference 01/29/10 Seattle
Dendreon’s New Operations Man, Acucela Enters Fast Growth Phase, JP Morgan Recap, & More Seattle-Area Life Sciences News 01/21/10 Seattle
Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial 01/20/10 Seattle
Amazon Closes Zappos Deal, RF Arrays Raises Cash, 16 Under the Radar Financings, & More Seattle-Area Deals News 11/03/09 Seattle
Under the Radar Deals: 16 Northwest Financings You Haven’t Heard About 10/28/09 Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News 08/13/09 Seattle
Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S. 08/10/09 National
Inside a Life Sciences Industry Confab: Notes from Convergence 06/17/09 Boston
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News 05/07/09 Seattle
Acucela Drug for Macular Degeneration Passes Early Safety Test 05/06/09 Seattle
Acucela Cuts Staff, Shifting Focus to Development of Eye Disease Drugs 10/03/08 Seattle
Seattle Entrepreneurs Call Bay Area VCs, Amazon Sells XOs, Tableau Taps $10M, ZymoGenetics Gives Up Drug Rights, & More Deals News 09/09/08 Seattle
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease 09/04/08 Seattle
Page 1 of 1